Completed PHASE3 INTERVENTIONAL 5-arm NCT01924013

Maternal Vitamin D for Infant Growth (MDIG) Trial (MDIG)

Randomized Placebo-controlled Trial of Maternal Vitamin D Supplementation During Pregnancy and Lactation to Improve Infant Linear Growth in Dhaka, Bangladesh.

Sponsor: Bill and Melinda Gates Foundation

Conditions Pregnancy

Interventions Placebo Vitamin D3 (cholecalciferol)

Updated 7 times since 2017 Last updated: Aug 29, 2018 Started: Mar 31, 2014 Primary completion: Mar 31, 2017 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01924013, this PHASE3 trial focuses on Pregnancy and remains completed. Sponsored by Bill and Melinda Gates Foundation, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Jun 2018 — Sep 2018 [monthly]

Active Not Recruiting PHASE3

▶ Show 2 earlier versions

May 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — May 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bill and Melinda Gates Foundation
International Centre for Diarrhoeal Disease Research, Bangladesh
Shimantik
The Hospital for Sick Children

Data source: The Hospital for Sick Children

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh